Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
INDIRECT CORNEAL NEUROTIZATION: LONG TERM OUTCOMES USING SURAL NERVE GRAFT.
Author Affiliations & Notes
  • Tania Albavera
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Guillermo Raul Vera-Duarte
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Alejandro Navas
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Arturo J Ramirez-Miranda
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Enrique O Graue-Hernandez
    Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico City, Mexico
  • Footnotes
    Commercial Relationships   Tania Albavera None; Guillermo Vera-Duarte None; Alejandro Navas None; Arturo Ramirez-Miranda None; Enrique Graue-Hernandez None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2663. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tania Albavera, Guillermo Raul Vera-Duarte, Alejandro Navas, Arturo J Ramirez-Miranda, Enrique O Graue-Hernandez; INDIRECT CORNEAL NEUROTIZATION: LONG TERM OUTCOMES USING SURAL NERVE GRAFT.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2663.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To report long-term clinical outcomes of patients with neurotrophic keratopathy and facial palsy secondary to neurosurgery treated with an indirect technique of corneal neurotization using sural nerve graft in a Neurosurgery Center in Mexico City.

Methods : This study included all subjects who underwent indirect corneal neurotization as part of a staged procedure for reanimation of the affected half of the face using a sural nerve graft coapted to the supratrochlear nerve and nerve fascicles sutured subconjunctivally to the perilimbal region, between July 2018 and June 2022 at the Department of neurosurgery center in Mexico City. Patients with neurotrophic keratopathy due to neurosurgery were prospectively recruited. Long-term follow-up was carried out with photographic evidence. Data on central corneal sensation (measured with Cochet-Bonnet aesthesiometer), best-corrected visual acuity, tear break-up time, corneal epithelial integrity, corneal stromal opacities, and corneal vascularization were collected.

Results : A total of 14 eyes of 14 patients underwent this surgical procedure. Mean age was 36.7 years (18 - 63) with a mean time to surgery of 21.4 months (9.2 - 47.1). All patients had partial to complete loss of corneal sensation before the procedure in all quadrants of the cornea. Within the follow-up period, mean 31.7 months (SD, + 6.2 months), all patients recovered corneal sensation and had resolution of epithelial defects; 11 patients (78.5%) improved visual acuity and 3 patients (21%) remained without visual changes. Regarding complications, two patients experienced graft-related granulomas, which subsequently resolved with the adjunct use of topical steroids. Conversely, unrelated to the graft itself but rather stemming from exposure, two patients encountered bacterial keratitis. Of these, one patient successfully responded to medical intervention, while the other patient's condition escalated to corneal perforation due to ulceration, necessitating a PKP. After three years of follow-up, a full analysis confirmed that a sural nerve graft applied to the eye's surface was safe and would stay there.

Conclusions : Corneal neurotization is new source of innervation that may improve ocular surface homeostasis and corneal sensation in patients with neurotrophic keratopathy.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×